Clinical Trial

Combining Aspirin With Cilostazol or Clopidogrel in Minor Stroke or TIA

Name: Combining Aspirin With Cilostazol or Clopidogrel in Minor Stroke or TIA — clinical trial record (NCT06591299)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

Along with the current clinical trial, the efficacy and safety of a 300 mg loading dose of clopidogrel administered within 24 hours of the first-ever minor stroke or TIA compared to 200 mg cilostazol were assessed through NIHSS, mRS, and possible adverse effects

Trial Details

NCT Number	NCT06591299
Lead Sponsor	Kafrelsheikh University
Conditions	Ischemic Stroke
Enrollment	870 participants
Start Date	2022-04-15
Primary Completion	2024-09-15 (estimated)
Study Completion	2024-09-30 (estimated)
Updated on ClinicalTrials.gov	2024-09-19